ID   F23
AC   CVCL_N322
SY   F.sub.23; URO3
DR   Wikidata; Q54833087
RX   Patent=US4713352;
RX   Patent=US4935344;
RX   PubMed=3857626;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8231.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human antigen URO3 on renal cancer cell lines.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 7
//
RX   Patent=US4713352;
RA   Bander N.H., Whitmore W.F. Jr., Old L.J.;
RT   "Monoclonal antibody panel for early diagnosis and therapy of renal
RT   carcinoma.";
RL   Patent number US4713352, 15-Dec-1987.
//
RX   Patent=US4935344;
RA   Bander N.H., Cordon-Cardo C., Finstad C.L., Whitmore W.F. Jr.,
RA   Melamed M.R., Oettgen H.F., Old L.J.;
RT   "Method for characterizing types of renal carcinoma and prognosis.";
RL   Patent number US4935344, 19-Jun-1990.
//
RX   PubMed=3857626; DOI=10.1073/pnas.82.9.2955;
RA   Finstad C.L., Cordon-Cardo C., Bander N.H., Whitmore W.F. Jr.,
RA   Melamed M.R., Old L.J.;
RT   "Specificity analysis of mouse monoclonal antibodies defining cell
RT   surface antigens of human renal cancer.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:2955-2959(1985).
//